Matches in Nanopublications for { ?s ?p "[Encouraging preclinical results with ado-trastuzumab emtansine (T-DM1) exemplifies a new potential treatment for HER2-positive BCa along with innovative bispecific antibodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- assertion description "[Encouraging preclinical results with ado-trastuzumab emtansine (T-DM1) exemplifies a new potential treatment for HER2-positive BCa along with innovative bispecific antibodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1247104.RAOw7T8JhwAIDRHPrRiF6Br3ou0UFTQzV2X-IuWTmAbWQ130_assertion description "[Encouraging preclinical results with ado-trastuzumab emtansine (T-DM1) exemplifies a new potential treatment for HER2-positive BCa along with innovative bispecific antibodies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247104.RAOw7T8JhwAIDRHPrRiF6Br3ou0UFTQzV2X-IuWTmAbWQ130_provenance.